NCT00051103 Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. Status COMPLETED Phase PHASE2
NCT00049998 Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00048360 Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults Status COMPLETED Phase PHASE3
NCT00048204 A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT00046332 A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients Status COMPLETED Phase PHASE2
NCT00046111 A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00044343 GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin Status COMPLETED Phase PHASE2
NCT00043927 Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults Status COMPLETED Phase PHASE3
NCT00043914 Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy Status COMPLETED Phase PHASE4
NCT00043901 Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug Status COMPLETED Phase PHASE4
NCT00043888 Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR Status COMPLETED Phase PHASE3
NCT00043862 The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) Status COMPLETED Phase PHASE2
NCT00041509 ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST) Status COMPLETED Phase PHASE2